These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 28164670)

  • 1. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Zhan B; Lu D; Luo P; Wang B
    Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
    Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Role of MicroRNAs in Human Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Lamichhane SR; Thachil T; De Ieso P; Gee H; Moss SA; Milic N
    Dis Markers; 2018; 2018():8309015. PubMed ID: 30538784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated miR-21 is associated with poor prognosis in non-small cell lung cancer: a systematic review and meta-analysis.
    Yuan Y; Xu XY; Zheng HG; Hua BJ
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4166-4180. PubMed ID: 30024605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.
    Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM
    Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
    Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
    Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155 expression has prognostic value in patients with non-small cell lung cancer and digestive system carcinomas.
    Xu TP; Zhu CH; Zhang J; Xia R; Wu FL; Han L; Shen H; Liu LX; Shu YQ
    Asian Pac J Cancer Prev; 2013; 14(12):7085-90. PubMed ID: 24460255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
    Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
    J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer.
    Yang M; Shen H; Qiu C; Ni Y; Wang L; Dong W; Liao Y; Du J
    Eur J Cancer; 2013 Feb; 49(3):604-15. PubMed ID: 23099007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer.
    Zhong KZ; Chen WW; Hu XY; Jiang AL; Zhao J
    Int J Clin Exp Pathol; 2014; 7(7):4545-51. PubMed ID: 25120851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis.
    Wang M; Ma X; Zhu C; Guo L; Li Q; Liu M; Zhang J
    Oncotarget; 2016 Dec; 7(49):81292-81304. PubMed ID: 27833074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR.
    He RQ; Cen WL; Cen JM; Cen WN; Li JY; Li MW; Gan TQ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 46(3):925-952. PubMed ID: 29669324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
    Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
    Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
    Zhao S; Qiu Z; He J; Li L; Li W
    Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
    Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma.
    Tejero R; Navarro A; Campayo M; Viñolas N; Marrades RM; Cordeiro A; Ruíz-Martínez M; Santasusagna S; Molins L; Ramirez J; Monzó M
    PLoS One; 2014; 9(7):e101899. PubMed ID: 25003366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
    Liu L; Qu W; Zhong Z
    Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS Mutation as a Biomarker for Survival in Patients with Non-Small Cell Lung Cancer, A Meta-Analysis of 12 Randomized Trials.
    Ying M; Zhu XX; Zhao Y; Li DH; Chen LH
    Asian Pac J Cancer Prev; 2015; 16(10):4439-45. PubMed ID: 26028111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.